Difference between revisions of "Part:BBa K5117011"

Revision as of 19:33, 30 September 2024

BsRBS-BsEglS

This part serves as translational unit composed of the ribosome binding site of Bacillus subtilis (BBa_K5117000) and the eglS gene of Bacillus subtilis (BBa_K5117001) encoding an endoglucanase (EC 3.2.1.4).

Target organism: Bacillus subtilis

Main purpose of use: Testing enzyme functionality in the host Bacillus subtilis

Sequence and Features

Enzyme characterization according to literature

The characterization of the enzyme included in this composite part can be found on the basic part page (BBa_K5117001) of the enzyme.

Construct Design

For compatibility with the BioBrick RFC[10] standard, the restriction sitesEcoRI, XbaI, SpeI, PstI and NotI were removed from the coding sequence (CDS). To make the part compatible with the Type IIS standard, BsaI and SapI sites were removed as well. This was achieved by codon exchange using the codon usage table of Bacillus subtilis (Codon Usage Database Kazusa). Upstream from the CDS, there is the ribosome binding site (RBS) for the host Bacillus subtilis followed by a 7 bp spacer. This composite part composed of RBS and CDS was flanked by the BioBrick prefix and suffix sequences and ordered via gene synthesis from IDT.

Construction of a template plasmid

In order to create a template from which this part could be amplified, the part was subcloned into a small vector pSB1C3 (Part:pSB1C3). For that purpose, the plasmid was isolated from E. coli DH10β, yielding a DNA concentration of 431.0 ng/µl. Afterwards, a Backbone PCR with pSB1C3 (Fig. 1) was performed, followed by a restriction digest of the amplified vector backbone and the part with EcoRI and PstI, which were purified via the HiYield® PCR Clean-up/Gel Extraction Kit (SLG, Germany), resulting in DNA concentrations of 32.6 ng/µl (digested pSB1C3) and 17.2 ng/µl.

After ligation, the plasmid was transformed into chemically competent E. coli DH10β cells. Transformants were selected by chloramphenicol resistance (35 µg/ml chloramphenicol) encoded on the pSB1C3 backbone. For the negative control, no DNA was added during the transformation procedure leading to no colony growth on selection plates. For the positive control, cells were transformed with the vector pSB1C3 resulting in a pink bacterial lawn due to the original RFP insert. On the selection plates of the target construct, white colonies were tested for the presence of the correct insert by Colony PCR and agarose gel electrophoresis (Fig. 2).

Colonies with a band at the correct size of the insert were chosen for plasmid isolation according to the HiYield® Plasmid Mini DNA Kit (SLG, Germany). Finally, the plasmid was verified via sequencing by Microsynth Seqlab GmbH (DNA concentration: 297.6 ng/µl).

Cloning into inducible expression vectors

For testing the functionality and activity of this enzyme, the part was cloned into xylose-inducible expression vectors in order to overexpress the gene of interest. Replicative (pBS0E-xylR-P_xylA) and integrative (pBS2E-xylR-P_xylA) vectors were used, both with a xylose-inducible promoter for induced expression and a xylose repressor to decrease basal promoter activity (Popp et al. 2017). Whereas replicative plasmids provide a high copy number and result in high concentrations of target proteins, genomic integration (in this case into the lacA locus) ensures high stability but results in lower protein concentrations. The vectors were isolated from E. coli DH10β, resulting in DNA concentrations of 151.9 ng/µl pBS0E-xylR-P_xylA and 127.6 ng/µl pBS2E-xylR-P_xylA. These vectors were digested with EcoRI and PstI (Fig. 3) and purified via gel extraction using the HiYield® PCR Clean-up/Gel Extraction Kit (SLG, Germany).

The enzyme part was amplified via PCR (Fig. 4) using the plasmid template pSB1C3-BsEglS and subsequently digested and purified via PCR clean up.

After ligation, the plasmids were transformed into chemically competent E. coli DH10β and transformants were selected by ampicillin resistance (100 µg/ml ampicillin) encoded on the vector backbone. White colonies transformed with the expression plasmids were analyzed by Colony PCR and agarose gel electrophoresis (Fig. 5). Colonies with a band the correct size of the insert were chosen for plasmid isolation. Finally, the replicative expression plasmid pBS0E-xylR-P_xylA-BsEglS and the integrative expression plasmid pBS2E-xylR-P_xylA-BsEglS were verified by sequencing and successfully generated (DNA concentrations: 601.3 ng/µl, 93.6 ng/µl).

Ultimately, these expression plasmids were transformed into the target host B. subtilis. Since this part was included in the strategy focused on the secretory expression of target enzymes, WB800N was chosen as an expression strain. This genetically engineered variant of B. subtilis W168 features the disruption of all extracellular proteases. The eight-extracellular-protease-deficient mutant is widely used in industrial applications, as it increases the stability of secreted proteins (Jeong et al. 2018). The transformants were selected by MLS resistance (1 micro;g/ml erythromycin and 25 micro;g/ml lincomycin) encoded on the vector backbones. The Bacillus transformation was carried out with early addition of DNA to growing WB800N cells (at OD₆₀₀ ≈ 0.7) to not miss the timepoint of competence. Afterwards, cells were grown until OD₆₀₀ ≈ 1.1-1.3 and the same procedure was followed as in the initial protocol (see Experiments page). The expression plasmids could be transformed into WB800N and colonies were verified by Colony PCR. The presence of replicative plasmids was tested by two primer pairs (double check), whereas both upstream and downstream integration into the lacA locus was checked for integrative plasmids (Fig. 6). Two colonies each with the correct insert size were chosen for cryo-conservation, serving as biological duplicates.

Expression of endoglucanases

For the expression and testing of heterologously expressed enzymes in B. subtilis, we induced protein production in cultures by adding 0.5 % xylose after reaching an OD₆₀₀ of 0.5 – 0.6. After 24 hours, the supernatants were collected to test secreted endoglucanases. The enzyme activity of the supernatants was tested, with additional samples analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to confirm protein expression. Detailed procedures are available on the Experiments page.

From now on, we will refer to B. subtilis WB800N transformed with the replicative vector pBS0E-xylR-P_xylA containing one of our enzymes, such as BsEglS, as "pBS0EX-BsEglS." Similarly, B. subtilis WB800N transformed with the integrative plasmid pBS2E-xylR-P_xylA containing the same enzyme will be referred to as "pBS2EX-BsEglS."

CMCase activity determination

To assess the CMCase activity of heterologously expressed endoglucanase BsEglS in B. subtilis, we initially performed a qualitative assay on 1%-CMC-Agar plate (see the Experiments page). We decided to test pBS0EX-BsEglS (replicative vector), assuming it would exhibit higher activity than pBS2EX-BsEglS (integrative vector).

Following the expression of BsEglS, induced with 0.5% xylose, we applied 15 µl of the supernatant to wells at the center of 1%-CMC-agar plates. The plates were incubated at 50 °C for 24 hours, after which we stained them using the congo red method to visualize enzyme activity, as shown in Fig. 7. The control strain WB800N and cultures without the addition of inducer were used as controls. Halo formation, indicating CMC degradation, was used to determine enzyme activity.

Negligible halos were observed on the plate of WB800N, suggesting only basal endoglucanase activity in the control strain, confirming the presence of the eglS gene in B. subtilis. Similarly, negligible halo formation was observed in the uninduced culture, indicating minimal endoglucanase expression without induction, with only basal enzyme activity from eglS being present.

In contrast, clear halos were observed for pBS0EX-BsEglS induced with xylose, indicating successful expression and activity of the endoglucanase compared to both the WB800N control and the uninduced culture. This demonstrates that the enzyme is effectively capable of degrading CMC.

DNS assay

To decide whether BsEglS (BBa_K5117011) or BpEglA ( BBa_K5117011) should be used for further immobilization on the spore surface, a discontinuous DNS assay (see Experiments page) was performed which is typically applied to estimate the amount of the reducing ends produced during the CMC degradation. At first, for this purpose a calibration curve was generated using calibration standards with glucose concentrations ranging from 200 μg/ml to 2000 μg/ml (see the Results page, DNS assay).

For the DNS assay, supernatants of pBS0EX-BsEglS and pBS0EX-BglA. The reaction was conducted with CMC diluted in 50 mM phosphate buffer (pH 7) at 50 °C for different time intervals (1 hour, 5 hours and 13 hours). DNS stop solution was then applied as described on the Experiments page, and the absorbance was measured at 540 nm. Controls included supernatants from B. subtilis WB800N, and supernatants from cultures without the addition of a protein expression inducer. Results are shown in Fig. 8.

Since B. subtilis naturally produces BsEglS, a notable background activity was detected after 13 hours of reaction, as previously shown with the qualitative CMC assay. However, this background activity did not interfere with the assessment of recombinant protein activity. The amount of reducing ends produced in samples from uninduced cultures containing plasmids with BsEglS and BpEglA genes was comparable to the WB800N control, reaching 161.68 μg/ml and 151.68 μg/ml, respectively, after 13 hours. Supernatants containing BpEglA led to the formation of 360.00 μg/ml reducing ends, while BsEglS-containing supernatants showed the highest activity, correlating with 500.00 μg/ml of reducing ends produced in 13 hours. Therefore, BsEglS was selected for further spore immobilization experiments.

Noteworthy, since the experiments were carried out with unpurified endoglucanases, the activity values were not standardized to the amount of enzyme responsible for the reaction, which led to limited comparability of the results. It is possible that BsEglS appears more active than BpEglA due to being produced in larger quantities by B. subtilis WB800N under the test conditions rather than having inherently higher activity. Additionally, the chosen discontinuous assay does not reflect the initial velocity of enzyme catalysis and could be influenced by factors such as thermostability. Despite these considerations, BsEglS remained the candidate for spore immobilization experiments, as it is naturally produced by B. subtilis, which may enhance its chances for successful production on the spore surface of this organism.

References

Jeong H., Jeong D. E., Park S. H., Kim S. J., Choi S. K. (2018): Complete Genome Sequence of Bacillus subtilis Strain WB800N, an Extracellular Protease-Deficient Derivative of Strain 168. Microbiol Resour Announc. 7(18), e01380-18. https://doi.org/10.1128/MRA.01380-18

Popp P. F., Dotzler M., Radeck J., Bartels J., Mascher T. (2017): The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis. Scientific reports 7(1), 15058. https://doi.org/10.1038/s41598-017-15107-z